The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells
- PMID: 37069013
- PMCID: PMC10300608
- DOI: 10.1016/j.breast.2023.04.001
The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells
Abstract
Since patients with triple-negative breast cancer do not respond to hormone therapy, the main treatment method is the combination of chemotherapy and radiotherapy. Because the DNA of the tumor cell is the target in both some chemotherapeutics and radiotherapy, problems may occur in individuals with a high DNA repair pathway. It is suggested that high expression of the Tip60 gene, which has an important role in repairing DNA damage, will increase the repair of DNA double-strand breaks in tumor cells, especially during radiotherapy treatment, thus reducing the response to treatment and adversely affecting treatment. In this study, for the first time, the role of the silenced and active Tip60 gene in response to radiotherapy in MDA-MB-231 and MCF-7 cells was investigated. For this purpose, the Tip60 gene was silenced by applying siRNA to the cell lines and UV was applied. In the study, cytotoxicity and DNA breaks were measured by MTT and COMET methods, and mRNA and protein expression values were measured by PCR and Raman spectrophotometer in silenced, unsilenced, UV-treated, and non-UV-treated cell lines. According to the results of the study, increased DNA damage was observed in MCF-7 cell lines in which the Tip60 gene was silenced, and radiotherapy was applied, compared to the cell lines with the Tip60 gene active. It was observed that DNA damage in MDA-MB-231 cell lines was less than in cell lines with the active Tip60 gene.
Keywords: Comet; MCF-7; MDA-MB-231; MTT; PCR; Protein expression; Tip60; siRNA.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that there is no conflict of interest that could be perceived as prejudicial to the impartiality of the reported research.
Figures







Similar articles
-
The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.Int J Mol Sci. 2023 Jun 2;24(11):9649. doi: 10.3390/ijms24119649. Int J Mol Sci. 2023. PMID: 37298600 Free PMC article.
-
The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation.Curr Mol Pharmacol. 2019;12(4):301-310. doi: 10.2174/1874467212666190503151753. Curr Mol Pharmacol. 2019. PMID: 31677257
-
HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.Oncotarget. 2016 Oct 4;7(40):64820-64835. doi: 10.18632/oncotarget.11706. Oncotarget. 2016. PMID: 27588488 Free PMC article.
-
TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer.Epigenomics. 2018 Nov;10(11):1415-1430. doi: 10.2217/epi-2018-0004. Epub 2018 Oct 16. Epigenomics. 2018. PMID: 30324811
-
BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions.Chem Biol Interact. 2010 Nov 5;188(2):350-8. doi: 10.1016/j.cbi.2010.03.046. Epub 2010 Apr 4. Chem Biol Interact. 2010. PMID: 20371364 Review.
References
-
- Kang H.S., et al. Diffusion kurtosis MR imaging of invasive breast cancer: correlations with prognostic factors and molecular subtypes. J Magn Reson Imag. 2022;56(1):110–120. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous